BlossomHill Therapeutics logo

BlossomHill Therapeutics Funding & Investors

BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders.

bhtherapeutics.com

Total Amount Raised: $173,000,000

BlossomHill Therapeutics Funding Rounds

  • Series B

    $100,000,000

    Series B Investors

    Colt Ventures
    Cormorant Asset Management
    OrbiMed Advisors
    Hercules Partners
    H&D Asset Management
    Vivo Capital
    Plaisance Capital Management
  • Series A

    $71,000,000

    Series A Investors

    Cormorant Asset Management
    OrbiMed Advisors
    Vivo Capital
    Hercules Bioventure Partners
  • Pre Seed

    $2,000,000

Funding info provided by Diffbot.